Back
Corcept Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
CORT
Corcept Therapeutics
Last Price:
$52.12
Seasonality Move:
11.1%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing slight buying pressure.
Corcept Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.52 | Sell |
| 20-day SMA: | 57.01 | Sell |
| 50-day SMA: | 53.64 | Sell |
| 200-day SMA: | 37.06 | Buy |
| 8-day EMA: | 53.38 | Sell |
| 20-day EMA: | 55.13 | Sell |
| 50-day EMA: | 52.89 | Sell |
| 200-day EMA: | 40.8 | Buy |
Corcept Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.66 | Sell |
| Relative Strength Index (14 RSI): | 36.34 | Sell |
| Chaikin Money Flow: | 167619 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.61 - 59.71) | Sell |
| Bollinger Bands (100): | (36.89 - 54.95) | Buy |
Corcept Therapeutics Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 50.90 while CORT 8-day simple moving average is 53.52, which is a Sell signal.
-
The stock price of CORT is 50.90 while Corcept Therapeutics 20-day SMA is 57.01, which makes it a Sell.
-
Corcept Therapeutics 50-day simple moving average is 53.64 while CORT share price is 50.90, making it a Sell technically.
-
CORT stock price is 50.90 and Corcept Therapeutics 200-day simple moving average is 37.06, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
62
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a BuyThe current Corcept Therapeutics [CORT] share price is $50.90. The Score for CORT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
5.3B
Price in USD:
50.90
Share Volume:
649.9K
Corcept Therapeutics 52-Week Range
52-Week High:
62.22
52-Week Low:
20.84
Buy
62
Corcept Therapeutics (CORT)
is a Buy
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?The Corcept Therapeutics stock price is 50.90 USD today.
-
Will CORT stock go up or go down?Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Corcept Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is not overvalued.
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 50.90 while CORT 8-day exponential moving average is 53.38, which is a Sell signal.
-
The stock price of CORT is 50.90 while Corcept Therapeutics 20-day EMA is 55.13, which makes it a Sell.
-
Corcept Therapeutics 50-day exponential moving average is 52.89 while CORT share price is 50.90, making it a Sell technically.
-
CORT stock price is 50.90 and Corcept Therapeutics 200-day simple moving average is 40.80, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.32 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
-
CORT Moving Average Covergence Divergence (MACD) indicator is -0.66, suggesting Corcept Therapeutics is a Sell
-
Corcept Therapeutics Relative Strength Index (RSI) is 36.34, which suggest Corcept Therapeutics is oversold
-
The Bollinger Bands (25) for Corcept Therapeutics is (53.61 - 59.71), which suggest Corcept Therapeutics is a Buy
-
The Bollinger Bands (100) for Corcept Therapeutics is (36.89 - 54.95), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.